Clinical Trial: Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: Long-term Open-label Extension Study to Assess the Safety, Tolerability, and Efficacy of Neramexane Mesylate in Congenital Idiopathic Nystagmus and Acquired Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Merz Pharmaceuticals GmbH

Dates:
Date Received: November 27, 2008
Date Started: May 2009
Date Completion:
Last Updated: June 30, 2010
Last Verified: June 2010